/

/

Master Trial Index (All Years)

/

REVIVAL

Category

Acute Kidney Injury & RRT

Full Summary

https://app.notion.com/p/3ab1a8cd5af181edb1dcea67100e207d

Journal

Intensive Care Med

Takeaway

Ilofotase alfa phase 3 did not improve 28d survival in sepsis-associated AKI, despite promising phase 2 signal.

Verdict

Null / Equivalence

Year

2024

myICUnotes © 2026 by Dr Abhijeet Anand is licensed under CC BY-NC-SA 4.0. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/